Posted in | News | Business | Energy | Chemistry

MPM Partners with Foton to Commercialize Skygas Gasifier

MPM Technologies, Inc. (OTCBB:MPML) announced that it has entered into a strategic alliance Agreement with Foton Technologies, LLC to develop projects utilizing Skygas gasification-derived syngas to produce power, chemicals, and liquid fuels via systems and processes designed and supplied by Foton.

The Consortium will work together to finalize projects jointly under development by the team and explore new worldwide markets.

MPM CEO Michael J. Luciano stated, “The MPM – Foton cooperation actually started back in early 2008, and we have been working on a number of projects, three of which are close to fruition. This agreement further reinforces our existing relation and greatly enhances our joint strength. Together we will be able to provide the best service and performance to our customers and users in the emerging waste-to-energy field.”

Foton CEO Don Hendrick noted that the Skygas gasifier was one of a very small number of gasifiers out of the hundreds of thermochemical processes vetted that met Foton’s stringent requirements for product gas quality and overall efficiency of operation.

Skygas™ is a unique electrokinetic process that converts solid and semisolid carbonaceous wastes into a clean-burning synthesis gas that can be utilized to produce power via steam or gas turbines or can be catalytically converted to synthetic chemicals or liquid fuels. Skygas™ overcomes the shortcomings generally associated with incineration and thermal and plasma arc gasification methods.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.